MACKAY SHIELDS LLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 51 filers reported holding HAEMONETICS CORP MASS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$25,825,110
+2.5%
29,294,000
-0.7%
0.71%
+0.7%
Q2 2023$25,204,736
+49.2%
29,499,000
+49.1%
0.70%
+51.9%
Q1 2023$16,891,280
+1.5%
19,791,000
-1.1%
0.46%
+9.4%
Q4 2022$16,635,976
+3.9%
20,012,0000.0%0.42%
+4.7%
Q3 2022$16,009,000
+103.0%
20,012,000
+99.9%
0.40%
+112.0%
Q2 2022$7,885,000
-5.7%
10,012,000
+0.9%
0.19%
+161.6%
Q1 2022$8,359,0009,919,0000.07%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2022
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders